Evidence map›Paper›PMID 36615587›Full record

ArticleMolecules (Basel, Switzerland)2023

Inhibition of Advanced Glycation End-Products by

Relwendé Justin Ouédraogo, Umair Aleem, Lassina Ouattara, Muhammad Nadeem-Ul-Haque, Georges Anicet Ouédraogo, Humera Jahan, Farzana Shaheen

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Molecules (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.1field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 6 citations in OpenAlex.

  1. Antiseizure Activity ofTurkish journal of pharmaceutical sciences · 2024
    Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Relwendé Justin OuédraogoUnit of Training and Research in Life and Earth Sciences, Department of Biochemistry-Microbiology, Nazi Boni University, Bobo-Dioulasso 01 BP 1091, Burkina Faso.ORCID 0000-0002-5036-2144
Umair AleemDr. Panjwani Center for Molecular Medicine and Drug Research, International Center for Chemical and Biological Sciences, University of Karachi, Karachi 75270, Pakistan.ORCID 0000-0001-8629-3550
Lassina OuattaraUnit of Training and Research in Life and Earth Sciences, Department of Biochemistry-Microbiology, Nazi Boni University, Bobo-Dioulasso 01 BP 1091, Burkina Faso.ORCID 0000-0001-5537-5246
Muhammad Nadeem-Ul-HaqueThird World Center for Science and Technology, Hussain Ebrahim Jamal Research Institute of Chemistry, University of Karachi, Karachi 75270, Pakistan.
Georges Anicet OuédraogoUnit of Training and Research in Life and Earth Sciences, Department of Biochemistry-Microbiology, Nazi Boni University, Bobo-Dioulasso 01 BP 1091, Burkina Faso.
Humera JahanDr. Panjwani Center for Molecular Medicine and Drug Research, International Center for Chemical and Biological Sciences, University of Karachi, Karachi 75270, Pakistan.ORCID 0000-0003-2052-9190
Farzana ShaheenThird World Center for Science and Technology, Hussain Ebrahim Jamal Research Institute of Chemistry, University of Karachi, Karachi 75270, Pakistan.ORCID 0000-0003-0057-3960
University of Karachi · PKNazi Boni University · BF

Funding

The World Academy of Sciences 3240316605
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

MitragynaTamarindusAnimalsGlycation End Products, AdvancedHepatocytesHumansMaillard ReactionMicePlant ExtractsTriterpenesGlycation End Products, AdvancedPlant Extractsquinovic acidTriterpenesantiglycationcytotoxicityMitragyna inermisswerosideTamarindus indica

Identifiers

PMID36615587
PMCPMC9823519
OpenAlexW4313433209

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.